1. Rizzetto M. Hepatitis D: thirty years after. J Hepatol. 2009;50(5):1043–50.
2. Wranke A, Pinheiro Borzacov LM, Parana R, Lobato C, Hamid S, Ceausu E, et al. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: the hepatitis delta international network (HDIN). Liver Int. 2018;38(5):842–50.
3. Miao Z, Zhang S, Ou X, Li S, Ma Z, Wang W, et al. Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection. J Infect Dis. 2020;221(10):1677–87.
4. Koh C, Da BL, Glenn JS. HBV/HDV coinfection: a challenge for therapeutics. Clin Liver Dis. 2019;23(3):557–72.
5. Koh C, Heller T, Glenn JS. Pathogenesis of and new therapies for hepatitis D. Gastroenterology. 2019;156(2):461–e1.